Who invested in Alnara Pharmaceuticals?
Alnara Pharmaceuticals's investors include Bessemer Venture Partners, MPM Capital, Frazier Healthcare Partners and Third Rock Ventures.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$55Mraised across 2 rounds since 2008, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by xconomy.com
From the SEC filings it signed: 3 on the team.
On the board, as filediAshley H. DombkowskiChristoph H. WestphalJames N. TopperRichard H. AldrichRobert H. Tepper
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Alnara Pharmaceuticals's investors include Bessemer Venture Partners, MPM Capital, Frazier Healthcare Partners and Third Rock Ventures.
Alnara Pharmaceuticals has raised $55M across 2 rounds since 2008.
Alnara Pharmaceuticals's most recent round was a Series B of $35M in Jan 2010.
Its most recent round, $35M in Jan 2010, is also its largest on record.
Alnara Pharmaceuticals's first round on record, in Oct 2008, was backed by Bessemer Venture Partners, Frazier Healthcare Partners and Third Rock Ventures.
Alnara Pharmaceuticals's latest named round is a Series B, in Jan 2010.
Alnara Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.